[1]
“Adverse Drug Reactions in Polypharmacy: A Real-World Pharmacovigilance Study Using EHR Data”, jibas, vol. 1, no. 1, pp. 10–19, Jul. 2025, doi: 10.65421/jibas.v1i1.6.